Apollo Hospitals declares Rs 10 interim dividend, Q3 PAT up 35%
APOLLOHOSP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.9 pts more than Nifty 100 and 2.7 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Board declared an interim dividend of Rs 10 per share (200% of face value Rs 5) for FY26. Record date is 16-Feb-2026, payment on or before 27-Feb-2026. Q3FY26 consolidated revenue grew 17% YoY to Rs 6,477 crore, EBITDA up 27% to Rs 965 crore, PAT up 35% to Rs 502 crore. YTD revenue Rs 18,623 crore, PAT Rs 1,412 crore (up 34%). Demerger scheme for pharmacy business into Apollo Healthtech pending NCLT approval.
Positive: Strong Q3 earnings growth and dividend declaration reward shareholders; demerger scheme for the pharmacy vertical continues to progress.